Clinical Trial: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Improving Neurological Prognosis and Safety after Mechanical Thrombectomy in Acute Cerebral Infarction by Modulating Inflammatory Response: A Prospective, Randomized, Blinded, Sham-Controlled Clinical Study (China)

China, Sept. 16 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for Improving Neurological Prognosis and Safety after Mechanical Thrombectomy in Acute Cerebral Infarction by Modulating Inflammatory Response: A Prospective, Randomized, Blinded, Sham-Controlled Clinical Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600132506

Registration Time: 2026/09/15

Type: Interventional study

Primary Sponsor: The First Affiliated Hospital of Fujian Medical University

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=341582

Published by HT Digital Content Services with...